Fungal infections cryptococcosis

Fungal infections, candidiasis, cryptococcosis PO 50 to 150 mg/kg/day in 4 equally divided doses. 

Posaconazole is similar in structure to itraconazole. It was well tolerated and as effective as fluconazole 100 mg in two large randomized comparisons in HIV-infected patients with oropharyngeal candidiasis. In a salvage study in patients with a variety of invasive fungal infections, there were response rates of 44-80% in patients with aspergillosis, fusariosis, cryptococcosis, candidiasis, and pheohyphomycoses after 4-8 weeks of therapy (1,2). 

Parenteral amphotericin B is indicated for the trcatmeot of severe, potentially life-threatening fungal infections, including dis.seminated forms of coccidioidomycosis and histoplasmosis. sporotrichosis. North American blastomycosb, cryptococcosis, mucormycosis, and aspergillosis. 

For fungal infections of the central nervous sy.stcm (CMS (c.g.. cryptococcosis), amphotericin B is mix with cerebrospinal fluid (CSF) that is obtained from a. spinal tap. Ihr solution of amphotericin B is then reinjected through Ac tap. For severe infections, this procedure may need to bt repeated many times. 

Fungal infections have emerged as a major cause of death among cancer patients and transplant recipients. In addition, patients with acquired immune-deficiency syndrome (AIDS) experience substantially more frequent and severe forms of cryptococcosis, histoplasmosis, coccidioidomycosis, and mucocutaneous (esophageal, oral, and vulvovaginal) candidiasis. 

Miconazole is indicated in the treatment of the following severe systemic fungal infections coccidioidomycosis, candidiasis, cryptococcosis, pseudoallescheriosis (petrielMo-sis, allescheriosis), paracoccidioidomycosis, and in the treatment of chronic mucocutaneous candidiasis. 

Fungal (histoplasmosis, coccidioidomycosis, cryptococcosis, Blastomyces dermatitidis infection)... 

---